Bristol-Myers Squibb Could Finally Go on the Market; Rumored Suitors Include Gilead, Pfizer, Novartis AG and Roche Post author:Sam Post published:February 13, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Theranos Quietly Settles Lawsuits With One of Its Biggest Investors May 1, 2017 Bay Area's CytomX Surges as Bristol-Myers Squibb Signs Up for 8 More Projects With $200 Million Upfront in Deal Totaling $5 Billion March 19, 2017 Dynavax Secures $175 Million in Funding to Support Launch of Recently Approved Heplisav-B February 19, 2018
Bay Area's CytomX Surges as Bristol-Myers Squibb Signs Up for 8 More Projects With $200 Million Upfront in Deal Totaling $5 Billion March 19, 2017
Dynavax Secures $175 Million in Funding to Support Launch of Recently Approved Heplisav-B February 19, 2018